It refers to the regression of non‐irradiated metastatic lesions following localised irradiation and is thought to result from radiation‐induced immunogenic cell death (ICD) and systemic activation of anti‐tumour immunity, particularly CD8+ T cells [11, 12]. The gene discussed is CD8A; the disease is neoplasm.